Skip to main content
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.80
+0.16 (1.09%)
Apr 24, 2025, 4:08 PM HKT

HKG:2196 Revenue

In the year 2024, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.07B CNY, down -0.80%. Shanghai Fosun Pharmaceutical (Group) had revenue of 10.16B in the quarter ending December 31, 2024, a decrease of -5.09%.

Revenue
41.07B CNY
Revenue Growth
-0.80%
P/S Ratio
1.42
Revenue / Employee
1.01M CNY
Employees
40,557
Market Cap
62.27B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202441.07B-332.34M-0.80%
Dec 31, 202341.40B-2.55B-5.81%
Dec 31, 202243.95B4.94B12.66%
Dec 31, 202139.01B8.70B28.72%
Dec 31, 202030.31B1.72B6.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeiGene 29.60B
Hansoh Pharmaceutical Group Company 13.05B
JD Health International 61.89B
WuXi Biologics 19.87B
Innovent Biologics 10.03B
Akeso 2.26B
Alibaba Health Information Technology 31.39B
CSPC Pharmaceutical Group 30.87B
Revenue Rankings

Shanghai Fosun Pharmaceutical (Group) News

More News